Internal Medicine, Sleep Medicine · The Villages, FL
NPI
1669405312
Since 2006
Specialty
Internal Medicine, Sleep Medicine
Code 207RS0012X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1501 N US Highway 441, Suite 1208
The Villages, FL, 32159
Phone (352) 751-0448
Groups this clinician bills Medicare through
Medicare paid, 2024
$640K
8,347 services
Medicare patients, 2024
1,716
Average age 78
Drug cost, 2024
$2.8M
4,310 prescriptions
Company payments, 2025
$2,313
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sergio L Balingit Jr. was code 99214 (office e&m - established), 2,754 times for 1,438 patients. In total Sergio L Balingit Jr. billed 8,347 services in 37 codes, and Medicare paid $640K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,754 | 1,438 | $95.08 | $262K |
| 94375 Pulmonary Function Testing | Office | 965 | 867 | $28.47 | $27K |
| 94200 Pulmonary Function Testing | Office | 963 | 866 | $10.99 | $11K |
| 94729 Pulmonary Function Testing | Office | 962 | 865 | $41.22 | $40K |
| 94727 Pulmonary Function Testing | Office | 958 | 863 | $32.43 | $31K |
| 99204 Office E&M - New | Office | 401 | 401 | $123.58 | $50K |
| 94617 Pulmonary Function Testing | Office | 335 | 310 | $65.20 | $22K |
| 94762 Pulmonary | Office | 312 | 281 | $18.39 | $5,738 |
| 95811 Sleep Study | Office | 230 | 226 | $481.22 | $111K |
| 95810 Sleep Study | Office | 91 | 91 | $463.68 | $42K |
| 99215 Office E&M - Established | Office | 68 | 44 | $139.52 | $9,487 |
| 99223 Hospital E&M - Initial | Facility | 67 | 64 | $134.59 | $9,018 |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 64 | 63 | $70.75 | $4,528 |
| 99291 Critical Care E&M | Facility | 32 | 25 | $167.28 | $5,353 |
| 99233 Hospital E&M - Subsequent | Facility | 23 | 19 | $92.38 | $2,125 |
By year: 2022 $636K for 8,267 services; 2023 $581K for 7,458 services; 2024 $640K for 8,347 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sergio L Balingit Jr. prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 503 prescriptions and refills. In total Sergio L Balingit Jr. wrote 4,310 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 503 | 778 | 127 | $496K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 382 | 590 | 94 | $273K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 304 | 382 | 149 | $8,845 |
| Montelukast Sodium Generic | 246 | 529 | 72 | $2,291 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 225 | 289 | 59 | $181K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 209 | 387 | 68 | $183K |
| Ipratropium Bromide Generic | 209 | 258 | 124 | $4,416 |
| Symbicort Budesonide/Formoterol Fumarate | 146 | 241 | 49 | $55K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 112 | 291 | 35 | $2,374 |
| Breo Ellipta Fluticasone/Vilanterol | 108 | 174 | 30 | $68K |
| Fluticasone Propionate Generic | 93 | 158 | 35 | $1,610 |
| Methylprednisolone Generic | 93 | 97 | 70 | $927 |
| Doxycycline Monohydrate Generic | 84 | 92 | 76 | $1,578 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 69 | 99 | 15 | $7,275 |
| Ofev Nintedanib Esylate | 69 | 75 | 13 | $1.0M |
Brand drugs: 2,217 claims; generic drugs: 2,093 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sergio L Balingit Jr. $2,313 ($2,313 in general payments such as food, travel and fees) from 16 companies. The largest payer was GlaxoSmithKline, LLC. with $400.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 18 | $400 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $312 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 20 | $235 |
| Verona Pharma, Inc. VRNA | 15 | $233 |
| Insmed, Inc. INSM | 9 | $180 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $166 |
| Grifols USA, LLC | 7 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $142 |
| Pulmonx Corporation LUNG | 5 | $110 |
| Genzyme Corporation SNY | 4 | $85.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.